Abstract: A process for sealing micro pores of micro-arc oxide film is disclosed in the present disclosure. The process may comprise the following steps: providing a piece of metal having a micro-arc oxide film; preparing a solution including ethyl silicate to make a sealing agent; dipping the metal in the sealing agent to form a coating on the film's surface.

Abstract: A process for sealing micro pores of micro-arc oxide film is disclosed in the present disclosure. The process may comprise the following steps: providing a metal coated with a micro-arc oxide film; blending a silicone resin and a diluting agent to make a sealing agent; daubing the sealing agent onto the micro-arc oxide film to form a coating on the film's surface.

Abstract: A process for sealing micro pores of micro-arc oxide film is disclosed in the present disclosure. The process may comprise the following steps: providing a metal coated with a micro-arc oxide film; providing a dipping solution including polyester methacrylate monomer for use as a sealing agent; and dipping the metal in the sealing agent to form a coating on the oxide film's surface.

Abstract: A process for sealing micro pores of micro-arc oxide film is disclosed. The process comprises the following steps: providing a piece of metal formed with a micro-arc oxide film; blending a polyurethane resin and a firming agent to make a sealing agent; spraying the sealing agent onto the micro-arc oxide film to form a coating on the film's surface. The process can also be: blending an epoxy resin and a firming agent to make a sealing agent to sealing the micro pores by spraying.

Abstract: A housing includes a plastic substrate, a transparent plastic film, and an intermediate layer sandwiched between the plastic substrate and the transparent plastic film. The intermediate layer includes a metallic coating formed on the transparent film and a protective coating formed on and covering the metallic coating. The plastic substrate is moldingly attached to the protective coating.

Abstract: The present invention provides methods for identifying agents capable of modulating RANK-mediated invention also provides pharmaceutical compositions and methods of using the same for treating osteoporosis or other diseases. The present invention is based on the functional and structural analysis of a novel RANK signaling motif that was found to play a distinct role in activating RANK-mediated intracellular signaling. This motif can be used to screen for RANK modulators. This motif for treating a variety of diseases that are caused by or associated with abnormal RANK expression or activities.

Abstract: The present invention relates to mutants of a blue multi-copper oxidase, comprising (a) a substitution of one or more amino acid residues with other amino acid residues, (b) an insertion of one or more amino acid residues and/or (c) a deletion of one or more amino acid residues, wherein the substitution, insertion or deletion is carried out at a position which is located no greater than 15 .ANG. from a Type I (T1) copper site. The present invention also relates to nucleic acid constructs comprising a nucleic acid sequence encoding the mutants of the present invention, host cells comprising the construct of the present invention, and methods for producing mutants of the present invention.

Abstract: The present invention relates to mutants of a blue multi-copper oxidase, comprising (a) a substitution of one or more amino acid residues with other amino acid residues, (b) an insertion of one or more amino acid residues and/or (c) a deletion of one or more amino acid residues, wherein the substitution, insertion or deletion is carried out at a position which is located no greater than 15 .ANG. from a Type I (T1) copper site. The present invention also relates to nucleic acid constructs comprising a nucleic acid sequence encoding the mutants of the present invention, host cells comprising the construct of the present invention, and methods for producing mutants of the present invention.